Antares Vision S p A: Terms and Exercise Ratio of Antares Vision Warrants

PRESS RELEASE

TERMS AND EXERCISE RATIO OF ANTARES VISION BSAs

Travagliato (Brescia), October 4, 2022 – Antares Vision SpA (“Antares Vision” or the “Company”) announces that, in accordance with Article 3 of the “Warrants Regulations Antares Vision SpA” (respectively, the “Warrants Regulations”1 and the “Warrants”), the Monthly Average Price for September 2022 is 8.1080 euros (source FactSet, Monthly Average Price calculated as the arithmetic mean of the official prices of the ordinary shares of Antares Vision SpA on the trading days of September ).

Thus, the Average Monthly Price of September 2022, equal to 8.1080 euros, being lower than the Exercise Price, equal to 9.50 euros, the Warrants cannot be exercised during the month of October 2022.

Antares Vision also announces that in September, exercise requests were received for a total of 30,000 Warrants. As a result, the Company issued 1,611 ordinary shares, for a total equivalent value of 161.10 euros (including 157.23 euros as issue premium), in accordance with the procedures provided for in the Warrants Regulation.

Following the exercise of the BSA Antares Vision, the new share capital of Antares Vision is 169,456.78 euros, divided into 69,121,137 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, without mention of nominal value for no category.

For any additional information, please refer to the BSA Regulations available on the Antares Vision website. www.antaresvision.com– “Investors – Investor Relations – Warrant” section.

ABOUT THE ANTARES VISION GROUP

Antares Vision Group is an outstanding technological partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, the competitiveness of companies and the protection of the environment. Antares Vision Group is a technological catalyst for supply chain transparency and sustainable transition, to protect the competitiveness of companies and the specificity of each country. The Company provides a unique and comprehensive ecosystem of technologies to ensure product quality (systems and inspection equipment) and end-to-end product traceability (from raw materials to production, from distribution to consumer), with integrated data, production and supply chain. management, also carried out through the application of artificial intelligence and the use of blockchains. Antares Vision Group is active in the life sciences sector (pharmaceutical, biomedical devices and hospitals), in the beverage, food and cosmetics industries, and has potential in other sectors. World leader in Track&Trace systems for pharmaceutical products, it provides large global manufacturers (more than 50% of the top 20 multinationals) and many government authorities with solutions to monitor their supply chains and validate the authenticity of products. Listed since April 2019 on the Italian Stock Exchange on the AIM (Alternative Investment Market) segment, and since May 14, 2021 on the STAR segment of the MTA (Electronic equity market), Antares Vision Group has achieved a turnover of 162 million euros. euro in 2020, operates in 60 countries, employs around 1,000 people and has a consolidated network of more than 40 international partners. More information please visit www.antaresvision.comand www.antaresvisiongroup.com

  • The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Settlement.

Sallie R. Loera